Washington, DC - “The FDA is adapting our regulatory approach to digital health technologies to accommodate the highly iterative nature of these tools. Our aim is to make sure that safe and effective advances can be made available to patients more efficiently,” said FDA Commissioner Scott Gottlieb, M.D. “As part of this process, we’re committed to soliciting feedback on our approach. In keeping with our mandate from Congress, we’re also committed to reporting on the impact of software functions that current law excludes from FDA regulation, such as general wellness software functions. Today’s effort is part of our work to obtain public input that will help shape our report to Congress about these software functions that we don’t regulate.”

Washington, DC - On Friday, May 25, 2018, the President signed into law:

Washington, DC - By the authority vested in me as President by the Constitution and the laws of the United States of America, including sections 1104(a)(1), 3301, and 7301 of title 5, United States Code, and section 301 of title 3, United States Code, and to ensure the effective functioning of the executive branch, it is hereby ordered as follows:

Bethpage, New York - President Trump at a Roundtable Discussion on Immigration:

Washington, DC - On Thursday, May 24, 2018, the President signed into law:

Washington, DC - Americans count on the Environmental Protection Agency every time they turn on the tap. Protecting public health and ensuring the safety of our nation’s drinking water is one of the agency’s top priorities. That’s why EPA is helping to lead the nation’s efforts to address a group of chemicals called Per- and Polyfluoroalkyl Substances or PFAS.